Commerzbank set a €42.00 ($48.84) price objective on Shop Apotheke Europe (ETR:SAE) in a research report released on Friday. The brokerage currently has a neutral rating on the stock.
SAE has been the subject of a number of other research reports. Hauck & Aufhaeuser set a €51.00 ($59.30) price objective on shares of Shop Apotheke Europe and gave the company a buy rating in a research report on Thursday, February 7th. Kepler Capital Markets set a €47.00 ($54.65) price objective on shares of Shop Apotheke Europe and gave the company a buy rating in a research report on Thursday, March 7th.
Shares of SAE opened at €39.40 ($45.81) on Friday. The stock has a market cap of $475.75 million and a PE ratio of -17.52. The company has a debt-to-equity ratio of 2.12, a current ratio of 2.85 and a quick ratio of 1.95. Shop Apotheke Europe has a 52 week low of €34.40 ($40.00) and a 52 week high of €56.00 ($65.12).
Shop Apotheke Europe Company Profile
Shop Apotheke Europe N.V. owns and operates online pharmacies in Germany, Austria, Belgium, the Netherlands, France, Italy, and Spain. The company provides non-prescription medications, over-the-counter medications, and pharmacy-related beauty and personal care products. It operates under the shop-apotheke.com brand in Germany; shop-apotheke.at brand in Austria; shop-pharmacie.fr brand in France; and farmaline brand in Belgium, Italy, and Spain.
Featured Article: Current Ratio
Receive News & Ratings for Shop Apotheke Europe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shop Apotheke Europe and related companies with MarketBeat.com's FREE daily email newsletter.